RCM
AMED

Rotella Capital Management’s Amedisys AMED Stock Holding History

Rotella Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,216
Closed -$441K – 15
2015
Q4 		$441K Buy
+11,216
New +$449K 0.39% 70

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rotella Capital Management's AMED Position: Q1 2016 in Review

Rotella Capital Management sold out of Amedisys (AMED) in Q1 2016, closing a stake of 11,216 shares — an estimated $441K sold.

Rotella Capital Management first reported a position in AMED in Q4 2015 and held it in 1 quarter. The position peaked at $441K in Q4 2015. 170 funds tracked by Wall St. Rank hold AMED as of Q1 2016.

  • Rotella Capital Management reported no remaining Amedisys position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 11,216 Amedisys shares in Q1 2016, an estimated $441K.
  • Rotella Capital Management first reported a position in Amedisys in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's Amedisys position peaked at $441K in Q4 2015.
  • 170 funds tracked by Wall St. Rank held Amedisys as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.